1. Home
  2. IDA vs ABVX Comparison

IDA vs ABVX Comparison

Compare IDA & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDA
  • ABVX
  • Stock Information
  • Founded
  • IDA 1915
  • ABVX 2013
  • Country
  • IDA United States
  • ABVX France
  • Employees
  • IDA N/A
  • ABVX N/A
  • Industry
  • IDA Electric Utilities: Central
  • ABVX
  • Sector
  • IDA Utilities
  • ABVX
  • Exchange
  • IDA Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • IDA 7.0B
  • ABVX 6.7B
  • IPO Year
  • IDA N/A
  • ABVX N/A
  • Fundamental
  • Price
  • IDA $131.91
  • ABVX $100.77
  • Analyst Decision
  • IDA Buy
  • ABVX Strong Buy
  • Analyst Count
  • IDA 7
  • ABVX 10
  • Target Price
  • IDA $133.00
  • ABVX $103.80
  • AVG Volume (30 Days)
  • IDA 414.6K
  • ABVX 1.1M
  • Earning Date
  • IDA 10-30-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • IDA 2.63%
  • ABVX N/A
  • EPS Growth
  • IDA 6.48
  • ABVX N/A
  • EPS
  • IDA 5.70
  • ABVX N/A
  • Revenue
  • IDA $1,809,996,000.00
  • ABVX $7,073,400.00
  • Revenue This Year
  • IDA $5.11
  • ABVX $4.44
  • Revenue Next Year
  • IDA $8.59
  • ABVX N/A
  • P/E Ratio
  • IDA $23.49
  • ABVX N/A
  • Revenue Growth
  • IDA N/A
  • ABVX N/A
  • 52 Week Low
  • IDA $100.10
  • ABVX $4.77
  • 52 Week High
  • IDA $138.03
  • ABVX $98.94
  • Technical
  • Relative Strength Index (RSI)
  • IDA 45.46
  • ABVX 74.51
  • Support Level
  • IDA $133.11
  • ABVX $90.85
  • Resistance Level
  • IDA $137.04
  • ABVX $94.26
  • Average True Range (ATR)
  • IDA 2.29
  • ABVX 3.46
  • MACD
  • IDA -0.66
  • ABVX 0.17
  • Stochastic Oscillator
  • IDA 15.06
  • ABVX 96.24

About IDA IDACORP Inc.

Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: